Open access
926
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus – Brief Report
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
Francesca Dapportoa VisMederi srl, Siena, ItalyCorrespondence[email protected]
https://orcid.org/0000-0001-7897-4452View further author information
Margherita Leonardia VisMederi srl, Siena, ItalyView further author information
, Claudia Maria Trombettab VisMederi Research srl, Siena, Italy;c Department of Molecular and Developmental Medicine, University of Siena, Siena, ItalyView further author information
, Claudia Semplicia VisMederi srl, Siena, ItalyView further author information
, Pietro Piua VisMederi srl, Siena, ItalyView further author information
, Giulia Piccinia VisMederi srl, Siena, ItalyView further author information
, Linda Benincasaa VisMederi srl, Siena, Italy;b VisMederi Research srl, Siena, ItalyView further author information
, Serena Marchic Department of Molecular and Developmental Medicine, University of Siena, Siena, ItalyView further author information
, Emanuele Andreanod Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, ItalyView further author information
, Piero Lovreglioe Interdisciplinary Department of Medicine, Section of Occupational Medicine, University of Bari, Bari, ItalyView further author information
, Nicola Buonvinof U.O.C. Penitentiary Medicine - Department of Territorial Care, Bari Local Health Authority, Bari, ItalyView further author information
, Nicola Decarog Department of Veterinary Medicine, University of Bari, Valenzano, ItalyView further author information
, Angela Stufanoe Interdisciplinary Department of Medicine, Section of Occupational Medicine, University of Bari, Bari, ItalyView further author information
, Eleonora Lorussog Department of Veterinary Medicine, University of Bari, Valenzano, ItalyView further author information
, Emilio Bombardierih Humanitas Gavazzeni, Bergamo, ItalyView further author information
, Antonella Ruelloh Humanitas Gavazzeni, Bergamo, ItalyView further author information
, Simonetta Vivianic Department of Molecular and Developmental Medicine, University of Siena, Siena, ItalyView further author information
, Rino Rappuolid Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy;i Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, ItalyView further author information
, Eleonora Molestia VisMederi srl, Siena, ItalyView further author information
, Alessandro Manentia VisMederi srl, Siena, ItalyView further author information
& Emanuele Montomolia VisMederi srl, Siena, Italy;b VisMederi Research srl, Siena, Italy;c Department of Molecular and Developmental Medicine, University of Siena, Siena, ItalyView further author information
show all
Article: 2129196
|
Received 28 Jul 2022, Accepted 22 Sep 2022, Published online: 21 Oct 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.